Gojek an Indonesia-headquartered ride-hailing and logistics company with operations in Indonesia, Vietnam, Singapore and Thailand, today announced that it has partnered with Singapore-based startup Doctor Anywhere, to offer offline and online medical consultations to its drivers. This announcement came after Gojek’s recent tie-up with Gigacover, a Singapore-based insurtech company, which offers prolonged medical insurance coverage for its drivers.

From April 1, all active drivers on Gojek will receive corporate access to Doctor Anywhere’s platform, with subscription fees fully paid for by Gojek. As part of the partnership, driver-partners will be entitled to a partner rate for each medical consultation, where they can be diagnosed and treated for common illnesses (such as fever, cough, sore throat, flu, diarrhea, headache, cold sore and skin conditions),  prescribed medication, and issued medical certificates and even referrals.

Under the partnership, Gojek driver-partners will also be eligible for discounts of up to 40% for various services provided by wellness partners on Doctor Anywhere’s marketplace.

The Singapore-based startup Doctor Anywhere, which is an on-demand video consultation platform that connects users to certified doctors, was founded in 2015 and raised $5.6m in a Series A funding led by Kamet Capital Partners in July 2018. The startup is also a participant of the Ministry of Health’s (MOH) regulatory sandbox for telemedicine providers, also known as the Licensing Experimentation and Adaptation Programme (LEAP) since September last year.

The LEAP initiative allows the safe development of new and innovative healthcare models to be piloted in a controlled environment.

Gojek is no stranger to the healthcare startup community as the company is an investor in the Series A funding of Indonesian-based health-tech platform Halodoc in September 2016. Just earlier this week, Halodoc announced that it had successfully raised US$65m in a series B funding led by new investor UOB Venture Management.

Source : MobiHealthNews


Please enter your comment!
Please enter your name here